🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pooja Hingorani

AbbVie (United States)

ORCID: 0000-0002-4772-7456
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children’s Oncology Group”.

Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children’s Oncology Group

Scientific Reports(2020)10.1038/s41598-020-69015-w
N/A
0DataRank · unranked
47 citations

Valentin Dinu, Xiyuan Zhang, Haiyan Lei, Jack F. Shern, Jin Hyoung Park +10 more

Phase II study of antidisialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma (AOST1421): A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10508
N/A
0DataRank · unranked
18 citations

Mark Krailo, Allen Buxton, Paul R. Hutson, J. Wade Davis, Katherine A. Janeway +3 more

Updated outcomes for patients with completely resected pulmonary recurrent osteosarcoma: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10023
N/A
0DataRank · unranked
3 citations

Mark Krailo, Ruxu Han, Allen Buxton, Damon R. Reed, Richard Görlick +5 more

Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0836
N/A
0DataRank · unranked
32 citations

Xiangjun Tian, Wendong Zhang, Zhongting Zhang, Rossana Lazcano, Pooja Hingorani +20 more

A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2885
N/A
0DataRank · unranked
0 citations

Alexander J. Chou, Allen Buxton, Joel M. Reid, Michael S. Isakoff, Lisa M. Kopp +12 more